Colorectal cancer (CRC) is among the three most common malignancies worldwide.1 Pathophysiologically, CRC development been linked to the acquisition of oncogenic mutations such as alterations in the phosphoinositide-3 kinase (PI3K)/Akt pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.